Registration number:
Ondine Biomedical Limited
for the Year Ended 31 December 2021
Ondine Biomedical Limited
Contents
Company Information |
|
Accountants' Report |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
Ondine Biomedical Limited
Company Information
Director |
C M Cross |
Registered office |
|
Accountants |
|
Chartered Accountants' Report to the Director on the Preparation of the Unaudited Financial Statements of
Ondine Biomedical Limited
for the Year Ended 31 December 2021
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ondine Biomedical Limited for the year ended 31 December 2021 which comprise the statement of income, balance sheet and the related notes, from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
https://www.icaew.com/regulation/a-z.
It is your duty to ensure that Ondine Biomedical Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Ondine Biomedical Limited. You consider that Ondine Biomedical Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Ondine Biomedical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
Use of our report
This report is made solely to the director of Ondine Biomedical Limited in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Ondine Biomedical Limited and state those matters that we have agreed to state to the director of Ondine Biomedical Limited, in this report in accordance with ICAEW Technical Release TECH 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ondine Biomedical Limited and its director for our work or for this report.
......................................
Chartered Accountants
Champions Way
Hendon
London
NW4 1PX
Ondine Biomedical Limited
(Registration number: 10570442)
Balance Sheet as at 31 December 2021
Note |
2021 |
2020 |
|
Current assets |
|||
Cash at bank and in hand |
|
|
|
Creditors: Amounts falling due within one year |
( |
( |
|
Net liabilities |
( |
( |
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Retained earnings |
( |
( |
|
Shareholder's deficit |
( |
( |
For the financial year ended 31 December 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
|
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. |
These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. The statement of income and the director's report are not delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small companies regime.
Approved and authorised for issue by the
.........................................
C M Cross
Director
Ondine Biomedical Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 December 2021
General information |
The company is a private company limited by share capital, incorporated in England. The registered office address is shown on page 1.
The principal place of business is:
888-1100 Melville Street
Vancouver
British Columbia
V6E 4A6
Canada
Accounting policies |
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A Small Entities and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention.
The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.
Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Going concern
The directors have received assurance from the shareholders to cover its liquidity requirements. On that basis the directors consider that the company will be able to meet its liabilities as the fall due for the foreseeable future, being a period of at least 12 months from the date on which these financial statements are approved.
Tax
The tax expense for the year comprises current and, where applicable, deferred tax. Tax is recognised in profit or loss, except that a charge attributable to an item of income or expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The company's liability for current tax is calculated using tax rates and laws that have been enacted or substantively enacted by the end of the reporting year.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that the recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against suitable future taxable profits.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
Current and deferred tax assets and liabilities are not discounted.
Cash at bank and in hand
This comprise cash at bank and in hand.
Ondine Biomedical Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 December 2021
Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Employee information |
The average number of persons employed by the company (including the director) during the year, was
Creditors: amounts due within one year |
2021 |
2020 |
|
Amount due to parent undertaking (see note 6 below) |
|
|
Accruals |
1,200 |
1,200 |
|
|
Share capital |
Allotted, called up and fully paid shares
2021 |
2020 |
|||
No. |
£ |
No. |
£ |
|
|
|
1,000 |
|
1,000 |
Ondine Biomedical Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 December 2021
Related party transactions |
Loans from related parties
2021 |
Parent undertaking |
At start of year |
|
Advances during the year |
|
At end of year |
|
|
2020 |
Parent undertaking |
At start of year |
|
Advances during the year |
|
At end of year |
|
|
Terms of loan from parent undertaking
Control |
The company's immediate parent company is
The ultimate parent company is
The company is controlled by C M Cross.